Media & Press Releases

FOR IMMEDIATE RELEASE


Contact:
Justin Andrews
eToims Medical Technology, UK and USA
jandrews@etoims.com
(P): +215-387-0550 extension 100
www.etoims.com

eToims® Medical Technology Launches Sports Development Program With Leading Football Franchise

London, UK, March 15, 2011


eToims® Medical Technology has announced an innovative Sports Development Program with a leading UK football franchise to refine and improve athletic therapy and conditioning. This partnership joins together the Sports Medicine and Science Department of one of the most recognized brands globally in sports with eToims®’s revolutionary patented system. Initial positive results include symptom improvement and enhanced recovery in individuals with nerve-related muscle symptoms.

Jennifer Chu, MD, Emeritus Associate Professor, former Director of Electrodiagnostic Medicine, Physical Medicine and Rehabilitation Department, University of Pennsylvania Medical School and eToims® inventor states: “The club’s football players whom I treated with eToims®, all showed very tight core muscles making them hip, knee and ankle injury prone. Similar injuries occur in tennis, track and other sports but studies show that professional football is 1000 times more injurious than other high risk occupations".

The non-invasive eToims ET127 device is used for surface stimulation of neuromuscular junctions (trigger points), in acute and chronic neuromuscular pain/discomfort conditions. eToims® reaches deep to produce twitch contractions of muscle fibers apposed to bone and joints. These characteristic twitches facilitate circulation to the deepest tissues by contraction and instantaneous relaxation of individual shortened, tight muscles, resulting in immediate improvement in pain/discomfort and physical function.

“The development of non-invasive techniques in electrodiagnosis is expected in 21st-century medicine,” said Bhagwan Shahani, MD, PhD (Oxon), past president of American Association of Neuromuscular and Electrodiagnostic Medicine and former Chairman and Professor Emeritus, Neurology and Rehabilitation Department, University of Illinois, Chicago College of Medicine. “I am excited that eToims® both mobilizes joints and relieves patients’ pain and discomfort. Clinicians are looking for new techniques to offer patients the ability to regain control of their lives by eliminating pain.”

Francis Bruyninckx, M.D., Director, Electrodiagnostic Medicine, Physical Medicine and Rehabilitation Department, University of Leuven, Belgium explains: " When too much muscle tightness and pain preclude the use of conventional exercise therapy, this treatment may still effectively exercise these tight, painful muscles--giving potential for eToims® as an exercise therapy over conventional methods. Unlike many forms of pain relieving medication, as a non-narcotic, eToims® has a unique and potentially groundbreaking ability to provide functional improvement with few contraindications and rare side effects".

If eToims® successfully returns the patient to work, remuneration for work would exert a positive effect on family and friends. Some medications, by clouding the mind and not helping function, do the opposite. eToims® is compatible with taking medication and has potential to decrease the amount of or end pain medications.

Devices are now available for sale across the European Union, Asia and Canada. Visit http://www.etoims.com

eToims® Medical Technology, LLC is ISO 134285:2003 certified in late 2009 and eToims® ET127 Evoked Response Stimulator received the CE Mark. The company, established in 2006 commercializes pioneering research in diagnosing and treating nerve-related muscle pain with non-invasive Electrical Twitch Obtaining Intramuscular Stimulation (eToims®), a unique and novel diagnostic therapy for healing nerve-muscle pain/discomfort related to sports, work, auto-accidents, repetitive motion, activities of daily living and aging.


###